Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerry Kenna

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
NMR in Biomedicine|April 9, 2013
Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibitionJose L Ulloa, Simone Stahl, James Yates, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|November 6, 2013
Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytesHelen Garside, Karen F Marcoe, Jessica Chesnut-Speelman, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 29, 2011
Evaluation of the pharmacokinetics, biotransformation and hepatic transporter effects of troglitazone in mice with humanized liversTimothy Schulz-Utermoehl, Sunil Sarda, John R Foster, et al.
Drug Discovery Today. Technologies|October 15, 2015
Systems toxicology: modelling biomarkers of glutathione homeostasis and paracetamol metabolismSimone H Stahl, James W Yates, Andrew W Nicholls, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 17, 2015
Activation of Flucloxacillin-Specific CD8+ T-Cells With the Potential to Promote Hepatocyte Cytotoxicity in a Mouse ModelRyan Nattrass, Lee Faulkner, Marc Vocanson, et al.
Biomarkers in Medicine|June 17, 2010
Recommendations to qualify biomarker candidates of drug-induced liver injuryJosef S Ozer, Raj Chetty, Gerry Kenna, et al.
Chemico-Biological Interactions|November 16, 2010
Risk assessment and mitigation strategies for reactive metabolites in drug discovery and developmentRichard A Thompson, Emre M Isin, Yan Li, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 6, 2011
A mathematical modelling approach to assessing the reliability of biomarkers of glutathione metabolismSuzanne Geenen, Franco B du Preez, Michael Reed, et al.
Biochimica Et Biophysica Acta|May 7, 2013
Glutathione metabolism modeling: a mechanism for liver drug-robustness and a new biomarker strategySuzanne Geenen, Franco B du Preez, Jacky L Snoep, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 22, 2016
An international network (PlaNet) to evaluate a human placental testing platform for chemicals safety testing in pregnancyPaul Brownbill, Igor Chernyavsky, Barbara Bottalico, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
NMR in Biomedicine|April 9, 2013
Assessment of gadoxetate DCE-MRI as a biomarker of hepatobiliary transporter inhibitionJose L Ulloa, Simone Stahl, James Yates, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|November 6, 2013
Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytesHelen Garside, Karen F Marcoe, Jessica Chesnut-Speelman, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 29, 2011
Evaluation of the pharmacokinetics, biotransformation and hepatic transporter effects of troglitazone in mice with humanized liversTimothy Schulz-Utermoehl, Sunil Sarda, John R Foster, et al.
Drug Discovery Today. Technologies|October 15, 2015
Systems toxicology: modelling biomarkers of glutathione homeostasis and paracetamol metabolismSimone H Stahl, James W Yates, Andrew W Nicholls, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 17, 2015
Activation of Flucloxacillin-Specific CD8+ T-Cells With the Potential to Promote Hepatocyte Cytotoxicity in a Mouse ModelRyan Nattrass, Lee Faulkner, Marc Vocanson, et al.
Biomarkers in Medicine|June 17, 2010
Recommendations to qualify biomarker candidates of drug-induced liver injuryJosef S Ozer, Raj Chetty, Gerry Kenna, et al.
Chemico-Biological Interactions|November 16, 2010
Risk assessment and mitigation strategies for reactive metabolites in drug discovery and developmentRichard A Thompson, Emre M Isin, Yan Li, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 6, 2011
A mathematical modelling approach to assessing the reliability of biomarkers of glutathione metabolismSuzanne Geenen, Franco B du Preez, Michael Reed, et al.
Biochimica Et Biophysica Acta|May 7, 2013
Glutathione metabolism modeling: a mechanism for liver drug-robustness and a new biomarker strategySuzanne Geenen, Franco B du Preez, Jacky L Snoep, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 22, 2016
An international network (PlaNet) to evaluate a human placental testing platform for chemicals safety testing in pregnancyPaul Brownbill, Igor Chernyavsky, Barbara Bottalico, et al.
Pageof 5